Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. 醫學院
  3. 臨床醫學研究所
Please use this identifier to cite or link to this item: https://scholars.lib.ntu.edu.tw/handle/123456789/568520
Title: Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
Authors: PEI-JER CHEN 
Lin J.-J.
Lu C.-S.
Ong C.-T.
Hsieh P.F.
Yang C.-C.
Tai C.-T.
Wu S.-L.
Lu C.-H.
Hsu Y.-C.
Yu H.-Y.
Ro L.-S.
Lu C.-T.
Chu C.-C.
Tsai J.-J.
Su Y.-H.
Lan S.-H.
Sung S.-F.
Lin S.-Y.
Chuang H.-P.
Huang L.-C.
Chen Y.-J.
Tsai P.-J.
Liao H.-T.
Lin Y.-H.
Chen C.-H.
Chung W.-H.
Hung S.-I.
Wu J.-Y.
Chang C.-F.
Chen L.
Chen Y.-T.
Shen C.-Y.
Issue Date: 2011
Publisher: Massachussetts Medical Society
Journal Volume: 364
Journal Issue: 12
Start page/Pages: 1126-1133
Source: New England Journal of Medicine
Abstract: 
BACKGROUND: Carbamazepine, an anticonvulsant and a mood-stabilizing drug, is the main cause of the Stevens-Johnson syndrome (SJS) and its related disease, toxic epidermal necrolysis (TEN), in Southeast Asian countries. Carbamazepine-induced SJS-TEN is strongly associated with the HLA B*1502 allele. We sought to prevent carbamazepine-induced SJS-TEN by using HLA-B*1502 screening to prospectively identify subjects at genetic risk for the condition. METHODS: From 23 hospitals in Taiwan, we recruited 4877 candidate subjects who had not taken carbamazepine. We genotyped DNA purified from the subjects' peripheral blood to determine whether they carried the HLA-B*1502 allele. Those testing positive for HLA-B*1502 (7.7% of the total) were advised not to take carbamazepine and were given an alternative medication or advised to continue taking their prestudy medication; those testing negative (92.3%) were advised to take carbamazepine. We interviewed the subjects by telephone once a week for 2 months to monitor them for symptoms. We used the estimated historical incidence of SJS-TEN as a control. RESULTS: Mild, transient rash developed in 4.3% of subjects; more widespread rash developed in 0.1% of subjects, who were hospitalized. SJS-TEN did not develop in any of the HLA-B*1502-negative subjects receiving carbamazepine. In contrast, the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (P<0.001). CONCLUSIONS: The identification of subjects carrying the HLA-B*1502 allele and the avoidance of carbamazepine therapy in these subjects was strongly associated with a decrease in the incidence of carbamazepine-induced SJS-TEN. Copyright ? 2011 Massachusetts Medical Society.
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953216429&doi=10.1056%2fNEJMoa1009717&partnerID=40&md5=e120d0c8b937a9202d3ae22a02a27791
https://scholars.lib.ntu.edu.tw/handle/123456789/568520
ISSN: 0028-4793
DOI: 10.1056/NEJMoa1009717
SDG/Keyword: carbamazepine; gabapentin; HLA B antigen; HLA B1502 antigen; imipramine; lamotrigine; naproxen; prednisolone; unclassified drug; adult; antigen detection; article; bipolar disorder; blister; clinical article; dizziness; drug eruption; drug fever; drug induced disease; epilepsy; fatigue; female; gastrointestinal disease; gene frequency; genetic risk; genetic screening; genotype; human; hypersensitivity; insomnia; maculopapular rash; male; mental disease; mouth ulcer; neuralgia; neuropathic pain; prevalence; priority journal; pruritus; screening test; sore throat; Stevens Johnson syndrome; Taiwan; tinnitus; toxic epidermal necrolysis; treatment duration; urticaria
[SDGs]SDG3
Appears in Collections:臨床醫學研究所

Show full item record

SCOPUSTM   
Citations

544
checked on Mar 6, 2023

WEB OF SCIENCETM
Citations

478
checked on Mar 19, 2023

Page view(s)

21
checked on Mar 26, 2023

Google ScholarTM

Check

Altmetric

Altmetric

Related Items in TAIR


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback